Several obstacles remain in the translation of muscle stem cell therapies to the clinic. First, our understanding of the precise molecular basis that differentiates self-renewing multipotent stem cells from progenitors that cannot engraft muscle fibers remains insufficient. We anticipate further work in this area to yield important breakthroughs on the mechanisms controlling the regenerative potential of MuSCs.



